Insider Sell: Chief Medical Officer Kamal Hamed Sells 39,496 Shares of Spero Therapeutics Inc

On September 13, 2023, Chief Medical Officer Kamal Hamed sold 39,496 shares of Spero Therapeutics Inc (NASDAQ:SPRO).

Related Keywords

,Gurufocus Value Of Spero Therapeutics Inc ,Spero Therapeutics Inc ,Gurufocus Value ,Spero Therapeutics ,Insider Trading ,Kamal Hamed ,Chief Medical Officer ,Iopharmaceutical Company ,Nsider Transaction ,